Sutent

Medicinal product

(Invented) name

Sutent

Active substance (s)

Sunitinibas

Strength

12,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX01, sunitinib

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2006-07-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

capsule, hard	1 vnt.
Sunitinibas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
28052	30588	1030588	buteliukas	N30		Receptinis	EU/1/06/347/001	Netiekiama	-	-	No	-	-
28053	30589	1030589	lizdinė plokštelė	N28		Receptinis	EU/1/06/347/004	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2006-07-19	Registruotas